BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Oct 18, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-10-16

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-10-16	Common Stock	M	20000	$17.33	Acquired	120413	Direct
2012-10-16	Common Stock	S	20000	$43.00	Disposed	100413	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-10-16	Stock Option (right to buy)	$17.33	M	20000	Disposed	2017-06-06	Common Stock (20000)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 plan executed on August 6, 2012.

F2: Options vest on November 7, 2007 and 1/48th on the 7th of each month thereafter.